Fibrosis occurs when inflammation activates immune cells and fibroblasts to release collagen and cytokines that remodel and ...

Glucagon-like peptide 1 receptor agonists (GLP-1RA) have made waves as treatments for obesity and type 2 diabetes, but a new report suggests they might also have clinical benefits for certain patients ...

“The results of our analysis showed that overall, patients with SCLC who survived to receive 3L treatment are a select group with exceptionally long 1L OS of 24.5 versus 14.9 months for ...

Craig See, MD, a cornea specialist for the Cole Eye Institute at Cleveland Clinic, emphasized that cornea injuries are ...

Elinzanetant provides a hormone-free treatment option for vasomotor symptoms by targeting the brain's thermoregulatory center ...

AMCP Nexus 2025 will focus on drug pricing, access, and reimbursement, influenced by the Inflation Reduction Act and One Big ...

The FDA has approved revumenib (Revuforj; Syndax Pharmaceuticals) for patients aged 1 year and older with relapsed or ...

Researchers have found that using mobile-app–based surveys and photography to remotely track and assess atopic dermatitis (AD ...

Midlife weight gain is a persistent challenge for many women, but emerging research suggests hormone therapy may enhance response to glucagon-like peptide-1 (GLP-1)–based treatments.

Extreme temperatures were found to exacerbate cardiovascular mortality in older patients with heart failure (HF), according to a new research letter published in JAMA Cardiology. 1 As human biology ...

US safety data show that elinzanetant caused few adverse events and no new liver-related concerns in women, James Simon, MD, explains. Nonhormonal treatment options for vasomotor symptoms continue to ...

Multigene next-generation sequencing (NGS) performed directly on tumor tissue can accurately identify pathogenic variants in epithelial ovarian cancer (EOC), detecting both somatic and germline ...